In adults with cancer and VTE, DOACs were noninferior to LMWH for recurrent, nonfatal VTE at 6 mo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37665989.
- Also identified by DOI 10.7326/J23-0067.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Schrag D, Uno H, Rosovsky R, et al; CANVAS Investigators. <b>Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial.</b> JAMA. 2023;329:1924-1933. 37266947.
Medical subject headings
- Neoplasms
- Venous Thromboembolism